Papers on dydrogesterone
29 papers4 new in 30 days
Sunday, November 15
Saturday, November 7
Maturitas
Risk of colorectal cancer and systemic menopausal hormone therapies: a Finnish cohort study

Cohort study of 364,304 peopleColorectal cancer
Saturday, October 31
Sunday, October 25
The Journal of Clinical Endocrinology and Metabolism
Reappraising the safety of menopausal hormone therapy for women-implications for the clinic

Monday, September 28
Tuesday, September 22
International Journal of Gynaecology and Obstetrics
Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper

CommentaryIndustry & policy
Tuesday, September 8
Tuesday, August 18
Wednesday, July 22
Post Reproductive Health
Tales from the clinic: options for perimenopausal bleeding, contraception and menopausal symptom control
Case seriesPerimenopause
Wednesday, June 17
International Journal of Women's Health
Effects of Menopausal Hormone Therapy on Uterine Fibroids in Women During Menopausal Transition
Cohort study of 83 peopleReproductive system
Thursday, May 28
Monday, May 25
Frontiers in Endocrinology
Efficacy and safety of dydrogesterone monotherapy versus estradiol-dydrogesterone combination therapy in perimenopausal women: a real-world cohort study
Cohort study of 150 peopleInterventions
Saturday, April 18
Reproductive Endocrinology
Resolution of the VII International Forum of Experts on Menopausal Hormone Therapy
ReviewIndustry & policy
Saturday, February 28
Reproductive Biomedicine Online
Decidual senescence in recurrent pregnancy loss: forkhead box M1-targeted progesterone treatment
Study of 10 peopleInterventions
Monday, February 9
Bleeding Thrombosis and Vascular Biology
Cardiovascular risk in hormone replacement therapy
Sunday, February 1
The Lancet Diabetes & Endocrinology
Menopausal hormone treatment and breast cancer
Saturday, October 18
Wednesday, October 30
Climacteric
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index
Randomized trial in 640 peoplePostmenopause
Wednesday, September 25
Maturitas
Ultra-low dose estradiol and dydrogesterone for the treatment of menopausal symptoms in a pooled, multi-ethnic population
Meta-analysis of randomized trialsMenopausal symptoms
Thursday, September 12
The American Journal of Psychiatry
Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Cohort study of 3,488 peopleHormone replacement therapy
Friday, December 1
Journal of Medical Economics
Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China
Computational studyMenopause
Tuesday, December 21
Gynecological Endocrinology
Dydrogesterone after 60 years: a glance at the safety profile
Systematic reviewInterventions
Saturday, September 25
Therapeutische Umschau Revue Therapeutique
Clinical evaluation of progestogens used in Menopausal Hormone Therapy (MHT)
Therapeutische Umschau Revue Therapeutique
Menopausal Hormone Therapy in women with other underlying diseases: how to proceed?
Sunday, September 19
Best Practice & Research Clinical Endocrinology & Metabolism
Menopausal hormone therapy and breast cancer risk
Wednesday, August 18
Climacteric
Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China
Randomized trial in 332 peopleMenopausal symptoms
Friday, October 30
BMJ
Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases
Case-control study of 457,498 peopleBreast cancer
Wednesday, September 25
Diabetes Therapy
Type 2 Diabetes Mellitus and Menopausal Hormone Therapy: An Update
ReviewInterventions



